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The objective was to describe and evaluate a model of drug dispensing developed and implemented 
in a community pharmacy in Brazil. This was a descriptive, observational, quasi-experimental study 
performed in the period between 21 January 2013 and 20 April 2013. The model was evaluated and 
described in terms of three parameters: structure, process and outcome. The description and assessment 
of each parameter was performed as follows: (I) Structure: profile of patients, pharmacist’s professional 
profile, physical facility, informational material; (II) Process: drug-related problems, pharmaceutical 
interventions performed, results of pharmaceutical interventions; (III) Outcome: patient knowledge of 
medications. Dispensing service improved patient knowledge of medications (p < 0.05), which was 
associated with pharmacotherapy complexity (p < 0.05). The main problems identified were related to 
lack of patient knowledge regarding their medication (52.9%). Pharmaceutical interventions were mostly 
performed directly to the patients (86.3%) by verbal (95.4%) and written (68.2%) information, and most 
of the problems were completely solved (62.7%). The medicine dispensing model was able to identify 
and solve drug-related problems and promote an improvement in patient knowledge about medication.
Uniterms: Community Pharmacy. Medicines/dispensing. Patients/directive counseling. Medication/
errors. Pharmaceutical Care. Quasi-experimental study.
O objetivo foi descrever e avaliar um modelo de serviço de dispensação de medicamentos desenvolvido 
e implantado em uma Farmácia Comunitária no Brasil. Trata-se de restudo descritivo, observacional e 
quase-experimental, realizado no período de 21 de janeiro a 20 de abril de 2013. A descrição e avaliação 
do modelo foi realizada segundo os parâmetros: estrutura, processo e resultado.Os aspectos descritos e 
avaliados foram: 1. Estrutura: perfil dos pacientes, perfil profissiográfico dos farmacêuticos, estrutura física, 
material de informação; 2. Processo: problemas relacionados ao medicamento detectados, intervenções 
farmacêuticas realizadas, resultados das intervenções farmacêuticas; 3. Resultado: conhecimento do 
pacientes sobre os medicamentos utilizados. A dispensação proporcionou melhora do conhecimento do 
paciente sobre os medicamentos (p < 0,05), que demonstrou-se associada à complexidade da farmacoterapia 
(p < 0,05). Foram identificados majoritariamente problemas relacionados à falta de condições do paciente 
em utilizar o medicamento (52,94%). As intervenções farmacêuticas foram realizadas predominantemente 
junto ao paciente (86,27%) através do fornecimento de informações verbais (95,4%) e escritas (68,2%) e, 
em sua maioria, o problema que originou a intervenção foi totalmente resolvido (62,75%).O serviço foi 
capaz de identificar e resolver os problemas relacionados ao medicamento e contribuiu para a melhoria do 
conhecimento dos pacientes relativo aos medicamentos utilizados.
Unitermos: Farmácia Comunitária. Medicamentos/dispensação. Pacientes/aconselhamento diretivo. 
Medicação/erros. Atenção farmacêutica. Estudo  quase-experimental.
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INTRODUCTION
According to the current legislation in Brazil, 
dispensing consists in “the pharmacist’s role in providing 
instructions, medications and medicinal products to a 
patient, as a remunerated work or not”(Conselho Federal 
de Farmácia, 2001).This definition is in accordance with 
regulatory documents in European countries and in the 
United States of America, as well as the recommendations 
developed by the World Health Organization (WHO). 
In these documents, there is a consensual concept that 
dispensing should incorporate the cognitive aspect of 
understanding the information contained in the drug 
prescription to the medication and to the patient, and 
convert them into individualized instructions in order to 
promote an appropriate use of the medication and increase 
the chances of therapeutic success (American Pharmacists 
Association, 1998; Angonesi, 2008; Foro de Atención 
Farmacéutica, 2008; World Health Organization, 2002). 
In addition, dispensing aims to identify drug-related 
problems (DRP), which are those situations that cause or 
may cause adverse effects associated with the use of drugs, 
and correct them by means of interventions (Angonesi, 
2008; Foro de Atención Farmacéutica, 2008).
Some researchers have proposed patient-focused 
structuring models of dispensing services that consider 
both cognitive and technical aspects in community 
pharmacies in Brazil and other countries such as Spain 
(Angonesi; Rennó, 2011; Foro de Atención Farmacéutica, 
2007; Soares et al., 2013). However, few studies have 
evaluated these models after their implementation.
The present study aimed to describe and evaluate a 
medicine dispensing model developed and implemented 
in a community pharmacy of a public university in Goias, 
Brazil.
METHODS
This was a descriptive, observational, quasi-
experimental study performed in a community pharmacy 
of a public, national university, located in Goiás, Brazil. 
This study was approved by the Research Ethics 
Committee of the Federal University of Goiás (number 
222/2012) and participants gave written informed consent 
before taking part.
Setting charachteristics
In Brazil, campus pharmacies are community 
pharmacies run by schools of pharmacy, and designed for 
academic education (Conselho Federal de Farmácia, 2008).
The following described process, which is now 
part of the routine service of the campus pharmacy (CP), 
was implemented in January 2012 aiming to establish 
a medication dispensing model in accordance with the 
National Policy of Pharmaceutical Assistance (Brasil, 
2004) and current legislation (Brasil, 2009, 2001; 
Conselho Federal de Farmácia, 2001). The model was 
based on previous experiences reported by Angonesi e 
Rennó (2001), Dáder et al. (2008), Iglésias-Ferreira and 
Santos (2009) and the Foro de Atención Farmacéutica 
(2007). In order to standardize each procedure and 
conduct, we established standard operating procedures, 
and performed the training of all pharmacists responsible 
for drug dispensing. 
Medication dispensing process at the CP is conducted 
in continuing steps to obtain personal and pharmacotherapy 
information about the patient, to understand and interpret 
drug prescription, to perform pharmaceutical interventions, 
and finally to dispense medications (Figure 1). It is worth 
pointing out that, since dispensing of compounding 
medications is also performed at the CP, not all steps 
illustrated in Figure 1 are performed in the presence of 
the patient. Interpretation of prescription, for example, 
is generally conducted in the interval between the 
compounding medication order and its dispensing.
Medications are dispensed to patients and/or their 
caregivers. Drug prescription is carefully examined for 
its comformity to Brazilian regulations (Brasil, 1973). 
Then, the patient is interviewed by a pharmacist regarding 
FIGURE 1 - Flowchart of the dispensing services routinely conducted at the Campus Pharmacy of the Federal University of Goias.
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personal data and information related to pharmacotherapy: 
age, sex, height, weight, occupation, allergies and other 
chronic diseases, use of medications, smoking and drinking 
habits, pregnancy and lactation. Also, the pharmacist asks 
whether the patient is aware of the aim of the therapy, how 
to take the medications, and verifies if expected results 
of the therapy are being achieved and the occurrence 
of adverse effects. All data are stored in a dedicated 
software for pharmaceutical data management, Pharmacie 
(Pharmasoftware, 2013). Finally, the pharmacist 
interprets the prescription according to an adaptation of 
the guidelines proposed by the Grupo de Investigações 
em Cuidados  Farmacêut icos  da Univers idade 
Lusófona, Portugal, (GICUF) (Group for Investigation 
on Pharmaceutical Care of Lusofona University, 
Portugal) (Iglésias-Ferreira, Santos, 2009) (Figure 2).
In this pharmacotherapy assessment tool, the five 
questions regarding each medication presented in the 
FIGURE 2 - Flowchart of the assessment of pharmacotherapy at the Campus Pharmacy of the Federal University of Goias. Adapted 
from: Iglésias-Ferreira, Santos, 2009.
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flowchart are sequentially answered. When a DRP is 
identified (i.e. when the answer to any of these questions 
is “no”), the assessment process is discontinued and the 
problem-solving process is initiated. According to the 
pharmacist’s clinical decision, each DRP may lead to 
pharmaceutical interventions, followed by the reassessment 
of the pharmacotherapy. These steps are successively 
repeated until the answers to all the questions are “yes”. 
The interventions can be directed to the person who made 
the prescription, the patient or the medication in use, in 
accordance with the Pharmaceutical Care Network Europe 
classification of DRP (Version 6.2) (Pharmaceutical 
Care Network Europe Foundation, 2010). At the end of 
the pharmacotherapy analysis, the pharmacist evaluates 
whether the patient needs other pharmaceutical services and 
refer the patient when deemed necessary. All DRP identified 
and pharmaceutical services performed are registered in the 
appropriate registration form of the CP. 
Medication is then dispensed and proper directions 
of use are provided by the pharmacist as recommended by 
the International Pharmaceutical Federation (International 
Pharmaceutical Federation, 2012). Medication information 
is provided orally or in written form. 
Description and assessment of the CP dispensing 
service
The description and assessment of the service was 
performed in terms of the three parameters: structure, 
process and outcome, used by Donabedian (2005) to 
evaluate the quality of medical care and adapted by Farris 
e Kirking (1993) to evaluate the quality of pharmaceutical 
care. 
The description and assessment of each parameter 
was performed as recommended by the Ministry of 
Health of Brazil (Brasil, 2006), international agencies 
(Morak et al., 2010) and previous studies (França 
Filho et al., 2008; Correr et al., 2004; Dewulf et al., 
2006; Donabedian, 2005; Fernández-Llimós et al., 
2002; Martins, 2012), as follows: (I) Structure: profile 
of patients, pharmacist’s professional profile, physical 
facility, informational material; (II) Process: drug-related 
problems, pharmaceutical interventions performed, results 
of pharmaceutical interventions; (III) Outcome: patient 
knowledge of medications.
Structure description
The profile of patients was defined by the following 
variables: sex, age, type of health service from which 
drug prescription was obtained (public or private), 
and complexity of pharmacotherapy, collected from 
the CP registration database (Pharmasoftware, 2013). 
Complexity of pharmacotherapy was calculated using 
the Medication Regimen Complexity Index (Melchiors, 
Correr, Fernández-Llimos, 2007) and dichotomized into 
low (< 7 points) and high (≥ 7 points)(Fröhlich, Pizzol; 
Mengue, 2010).
Pharmacists’ professional profile was defined by the 
following variables: the time elapsed since graduation, 
postgraduate course, graduate degrees, refresher courses in 
the area completed within the last 5 years, and attendance 
in symposium and conferences in the last 5 years. These 
data were obtained from the pharmacists’ résumé available 
at the National Council for Scientific and Technological 
Development website (Brasil, 2013a). 
The informational material was described according 
to updating of the content and classification of the source 
of information (primary, secondary, tertiary).
Process description
The duration of each stage of the dispensing service 
was recorded by the pharmacists, who used a digital 
chronometer. The first service was determined as the 
time elapsed between the moment the patient presented 
the prescription to the pharmacist and the moment the 
patient left the drug dispensing table. The time taken for 
the interpretation of the prescription was determined by 
the time taken by the pharmacist to start and conclude 
the prescription analysis if no DRP was detected, or by 
the time taken by the pharmacist to start the prescription 
analysis and detect the first DRP. The time for dispensing 
was defined by the time elapsed between the moment the 
patient ordered the prescribed drug and the moment the 
patient left the drug dispensing table.
DRPs were classified according to the parameters 
proposed by the GIGUF (Iglésias-Ferreira, Santos, 
2009). Pharmaceutical interventions were classified 
according to the Pharmaceutical Care Network Europe – 
PCNE V6.2 classification(Pharmaceutical Care Network 
Europe Foundation, 2010). To each DRP, more than one 
intervention could be made. 
All data were obtained from the CP registration 
database.
Outcome evaluation
Patients or their caregivers (age ≥ 18 years old) who 
attended the dispensing service in the period between 
21 January 2013 and 20 April 2013 participated in the 
outcome evaluation stage. Informed consent was obtained 
from all participants.
Exclusion criteria included communication 
impairment, clinical limitations, situations when the 
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medication was dispensed to other individuals different 
from the patients or their caregivers, participants who did 
not answer all questionnaires.
The outcome evaluation questionnaires were applied 
in a pretest-postest design: first, by the pharmacist, 
when the patient ordered the medication at the campus 
pharmacy; second, by a trained telephone interviewer, 30 
days following dispensing (Figure 3).
Patient knowledge of medication was assessed by a 
validated questionnaire (Fröhlich, Pizzol, Mengue, 2010), 
which was developed to evaluate the level of knowledge 
about drug prescription in the primary health care in 
Brazil. When more than one medication was dispensed, the 
questions were asked regarding the first medication listed on 
the prescription. The first question (“What’s the name of the 
prescribed medicine?”) was excluded from the evaluation, 
since the telephone interviewer stated which medication the 
patient would be asked about. The final classification point 
was adapted and appropriately corrected for this exclusion. 
Patients’ level of knowledge about drug prescription was 
dichotomized into low (< 8 points) and high (≥ 9 points) 
(Fröhlich, Pizzol, Mengue, 2010).
Patients were categorized into two groups according 
to their level of knowledge about medication: (I) persistent 
low level of knowledge: patients who had a low level of 
knowledge before and after the pharmaceutical service; 
(II) increased level of knowledge: patients who had a 
low level of knowledge about drug prescription before 
the pharmaceutical service, and achieved a high level of 
knowledge after the service. 
Data analysis
All data collected was stored in a Epi Info 3.5.4 
(Centers for Disease Control and Prevention, 2012) 
database, and analyzed by using the STATA software, 
version 12 (Statacorp, 2011). Comparisons between the 
level of knowledge about drug prescription before and 
after medicine dispensing were performed by McNemar’s 
test. A p-value < 0.05 was considered to be statistically 
significant. Associations between variables were assessed 
by the Wald test. 
RESULTS
Structure description
During the study period 769 users attended the 
pharmacy, and 170 users met the inclusion criteria. Of 
these, 48 did not complete the data collection instrument 
in the second assessment, 16 did not return to the pharmacy 
to get the medication ordered and 02 did not receive their 
medications due to DRPs. Hence, a total of 104 patients 
completed the study.
Most participants were women (80.8%), aged ≥ 40 
years (66.0%), users of the public health service (54.0%), 
who had previously attended the CP (63.5%), following a 
low-complexity pharmacotherapy regimen (80,8%).
Two pharmacists were responsible for the drug 
dispensing during the study. They had graduated at least 
5 years before the beginning of the study, both of them did 
specialization courses, and one of them had a Master’s 
degree. Also, they have attended refresher courses in 
the area, symposium and conferences within the last 
5 years.
The sources of informations used in the study 
were of primary and secondary types - list of scientific 
journals and database such as Micromedex® e Drugdex®, 
available at the Capes website (BRASIL, 2013b), and 
tertiary - a comprehensive bibliography.
Dispensing was performed with the patient seated 
comfortably in appropriate physical facilities,including 
tables, chairs and private room if needed.
Process description
The average time for the stage of ‘medicine 
ordering’ was 448.30 s (SD = 263.52, Minimum = 32, 
Maximum = 1284), for ‘interpretion of prescription’ was 
109.87 s (SD = 109.87, Minimum = 5, Maximum = 532), 
and for ‘medicine delivery’ was 130.02 s (SD = 122.05, 
Minimum = 16, Maximum = 663).
The dispensing service at the CP was able to identify 
DRPs and correct them by means of pharmaceutical 
interventions. The main DRPs identified were related to 
the lack of patient’s knowledge regarding their medication 
(Table I).
Pharmaceutical interventions were made directly to 
the patient, by verbal information (Table II).
Outcome evaluation
The dispensing process developed by the group 
increased patient knowledge about medication. More than 
FIGURE 3 - Assessment timepoints of patient knowledge of 
medication in the evaluation of the dispensing service.
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50% of patients achieved a high level of knowledge after 
the dispensing process (p = 0.0001) (Table III). 
Association between structure, process and 
outcome 
The majority of the pharmaceutical interventions 
were performed in patients aged greater than 60 years and 
in users of the public health system (Table IV).
The increase in the level of patients’ knowledge 
about their medications was associated with the complexity 
of pharmacotherapy (Table V).
DISCUSSION
These findings suggest that the dispensing process 
developed and implemented in the CP provided patient 
counseling on medication use, hence increasing patient 
knowledge about medications and chances of therapeutic 
success. 
The lack of patient knowledge of medications 
may result in poor adherence and a negative impact on 
the therapy success, due to pharmacotherapy failure, 
increased incidence of adverse effects and intoxications, 
and deterioration in health status (Fernandes, Pires, 
Gouvêa, 2002; Margonato, Thomson, Paoliello, 2008; 
Oenning; Oliveira; Blatt, 2011). This is also evident in 
previous studies, as reported by Margonato et al. (2008), 
correlating the incidence of hospitalization secondary 
TABLE I - Drug related problems identified during the dispensing 
process at Campus Pharmacy, Goias, Brazil, 2013
Variables n (%)
Inappropriate medication 13 (25.5)
Drug interaction 9 (69.2)
Possible adverse reaction 2 (15.4)
Therapy duplication 2 (15.4)
Inappropriate posology 11 (21.6)
Dose not specified 6 (54.5)
Treatment duration not identified 5 (45.5)
Insufficient dose 3 (27.2)
Inappropriate route of administration 1 (9.1)
Route of administration not identified 1 (9.1)
Schedule of administration not identified 1 (9.1)
Lack of patient’s knowledge 27 (52.9)
Patient does not know how to use 
medication appropriately 
15 (55.6)
Patient does not know about food-drug 
interactions 
8 (29.6)
Non adherence 8 (29.6)
Difficulty in understanding how to use 
medication appropriately 
6 (22.2)
Patient can not afford medication 5 (18.5)
Patient does not know the treatment 
duration 
4 (14.8)
Patient does not know how to store the 
medication
3 (11.1)
Patient does not know about adverse effects 2 (7.4)
Patient does not know about drug-drug 
interactions 
2 (7.4)
Patient does not know the time for medicine 
to take effect 
1 (3.7)
Patient does not know the purpose of the 
treatment 
1 (3.7)
TOTAL 51 (100.0)
TABLE II - Pharmaceutical interventions performed during the 
dispensing process at Campus Pharmacy, Goias, Brazil, 2013 
(n=51)
Intervention domain n (%)
No intervention 3 (5.9)
Prescriber 9 (17.6)
Prescriber was informed  7 (77.8)
Intervention proposed, not approved by 
prescriber
2 (22.2)
Patient 44 (86,3)
Verbal information provided only 42 (95.4)
Writteninformationprovidedonly  30 (68.2)
Patient referred to prescriber  7 (15.9)
Drug 8 (15.7)
Dosage changed to… 5 (62.5)
Instructions for use changed to... 6 (75.0)
Outcome of intervention n (%)
Not known Outcome of intervention not 
known
11 (21.6)
Solved Problem totally solved 32 (62.7)
Partially solved Problem partially solved 2 (3.9)
Not solved 6 (11.8)
Problem not solved, lack of cooperation of 
patient
1 (16.7)
Problem not solved, lack of cooperation of 
prescriber 
2 (33.3)
No need or possibility to solve problem 3 (50.0)
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to non intentional, acute poisoning by medications 
with the lack of instructions for medication use at the 
time of dispensing. The increase in the knowledge 
level may increase the chances of the pharmacotherapy 
success, as evidenced by Angelini et al. (2009) in a 
study demonstrating that the improvement of patients’ 
knowledge on the management of inhaled corticosteroid 
during an education program was associated with 
patients’ clinical progress.
In the process description, we have found that most 
TABLE III - Patient knowledge about medications before and after the dispensing process at the Campus Pharmacy, Goias, Brazil, 
2013 (n=104)
Level of knowledge about medication
After dispensing 
n (%)
p*
Low level of 
knowledge 
High level of 
knowledge Total
Before dispensing 
n (%)
Low level of knowledge 27 (44.3) 34 (55.7) 61 (100.0)
0.0001
High level of knowledge 9 (20.9) 34 (79.1) 43 (100.0)
Total 36 (100.0) 68 (100.0)
* McNemar test
TABLE IV - Pharmaceutical interventions and associated factors performed during the dispensing process at the Campus Pharmacy, 
Goias, Brazil, 2013
Characteristics of prescription 
Number of 
prescriptions 
dispensed  
n (%)
Prescriptions 
that required 
interventions 
n (%)
PR [95% CI] p*
Patient-related     
Sex    0.73
 Female 84 (80.8) 30 (35.7) 0.7 (0.3 – 1.5)
 Male 20 (19.2) 5 (25.0) 1.00
Age 0.02
 18 - 40 years 29 (28.2) 4 (13.8) 1.00
 41 - 60 years 35 (34.0) 14 (36.8) 2.7 (1.0 – 7.3)
 ≥ 60 years 33 (32.0) 17 (50.0) 3.73 (1.4 – 9.9)
Drug-related 
Complexity of Pharmacotherapy 0.06
 Low 20 (19.2) 10 (50.0) 1.7 (0.9 – 2.9)
 High 84 (80.8) 25 (29.8) 1.0
Health service-related   
Was the prescription originated from the public 
health system?
0.01
 Yes 47 (54.0) 25 (53.2) 2.3 (1.2 – 4.3)
 No 40 (46.0) 9 (22.5) 1.00
First time using the dispensing services at the 
Campus Pharmacy 
0.12
 Yes 66 (63.5) 26 (39.4) 0.6 (0.3 – 1.2)
 No 38 (36.5) 9 (23.7) 1.00
CI95%: 95% confidence interval; RP: prevalence ratio * Wald test 
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of the DRPs identified were related to the fact that the 
patient did not know how to use medication appropriately. 
The pharmaceutical interventions were then performed by 
written and verbal instructions, given directly to the patient. 
This finding is corroborated by previous studies conducted 
in community pharmacies in Brazil and Germany (Nicolas 
et al., 2013; Oenning, Oliveira, Blatt, 2011), revealing that 
patient’s knowledge about medications and their correct 
use was limited. These results support the importance of 
taking the time of dispensing as an opportunity to provide 
the patient with instructions for medication use. 
In this study, the improvement in patient knowledge 
of medications was associated with the complexity of 
pharmacotherapy. One possible explanation for this is that 
patients with a high medication regimen complexity index 
tend to be more attentive to the instructions provided by 
the pharmacist during the dispensing process. Another 
possibility is that the pharmacist is more likely to provide 
the patients with complex medication regimens with better 
care during dispensing.
In comparison to a similar study previously 
conducted in the south of Brazil (Oenning, Oliveira, 
Blatt, 2011), a greater improvement in patient’s level 
of knowledge of medication after dispensing was found 
in our study. This may be explained by differences 
regarding the pharmacy structure, including the quality 
of informational materials, and pharmacists’ academic 
background. The structure of the CP in our institution is 
considerably distinct from pharmacies located in other 
parts of Brazil (França Filho et al., 2008; Correr et al., 
TABLE V - Factors associated with the increase in the level of patient knowledge about medication during the dispensing process 
at the Campus Pharmacy, Goias, Brazil, 2013
Characteristics Total of patients
Patients with 
increased level 
of knowledge 
Odds ration 
[CI=95%] p*
Patient-related
Sex  0.51
 Female 84 (80.8) 55 (65.5) 1.0
 Male 20 (19.2) 13 (65.0) 0.7 (0.3 – 1.8)
Age  0.67
 18 - 40 years 29 (28.2) 21 (72.4) 1.0
 41 - 60 years 35 (34.0) 24 (68.6) 1.4 (0.6 – 3.0)
 ≥ 60 years 33 (32.0) 20 (60.6) 1.4 (0.6 – 3.2)
Drug-related 
Complexity of Pharmacotherapy 0.00
 High 20 (19.2) 9 (45.0) 2.3 (1.3 – 4.1)
 Low 84 (80.8) 59 (70.2) 1.0
Health service-related
User of the Brazilian public health system? 0.13
 Yes 47 (54.0) 29 (61.7) 1.7 (0.8 – 3.6)
 No 40 (46.0) 27 (67.5) 1.0
Utilization of dispensing services at the Campus 
Pharmacy for the first time?
0.20
 Yes 66 (63.5) 41 (62.1) 1,0
 No 38 (36.5) 27 (71.0) 0.6 (0.3 – 1.3)
Dispensingprocess-related
Was an intervention made? 0.36
 Yes 35 (33.6) 21 (60,0) 1.3 (0.7 – 2.4)
 No 69 (66.4) 47 (68,1) 1,0
CI95%: 95% confidence interval; PR: prevalence ratio. * Wald test
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2004; Henningen, 2007; Lucchetta, Mastroianni, 2010; 
Silva,Vieira, 2004), where pharmaceutical care decisions 
are also strongly influnced by pharmaceutical industries. 
Our study demonstrated that by applying the 
dispensing procedures adapted from the GICUF (Iglésias-
Ferreira, Santos, 2009), DRPs were identified and 
completely solved by more than 60% of the pharmaceutical 
interventions performed. This is explained by the fact 
that the DRPs identified in the CP, including incomplete 
prescriptions, prescribing errors, drug-drug interactions 
and lack of patient knowledge, can be prevented. On the 
other hand, these DRPs may have a negative impact on 
patient’s health, if not identified or maintained unsolved.
The demand for pharmaceutical interventions was 
associated with age greater than 60 years, which may 
be explained by the higher frequency of DRPs detected 
in elderly patients (Buurma et al., 2001). This is a 
relevant data considering that the elderly population has 
increased worlwide. For example, the older population 
has doubled in the last 20 years in Brazil (Brasil, 2013c), 
and is estimated to be between 10-37% of people living in 
European Union countries (Giannakouris, 2010). 
Also, the prevalence of interventions was higher 
in patients with drug prescriptions that derived from the 
public health system, which is a major source of low 
quality prescriptions, as reported by Lyra Junior et al. 
(2004). These authors indicate that prescription and 
medication errors may cause DRPs, and the involvement 
of a pharmacist in the dispensing process would prevent 
or minimize such mistakes. DRPs have been frequently 
identified in drug prescriptions even in countries with very 
different health systems (Buurma et al., 2001; Nicolas et 
al., 2013), including European countries.
In this study, the pharmacist was responsible for the 
approach of most of the DRPs identified, and only in few 
situations, the prescriber had to be contacted. This is in 
agreement with other studies (Indermitte et al., 2007; Lyra 
Junior et al., 2004) on pharmaceutical interventions in the 
dispensing process, demonstrating that the pharmacists 
deal with a variety of DRPs, without requiring the 
involvement of other health care providers. 
Finally, the average time taken for the dispensing 
process was 11.5 minutes.  As compared to the 
pharmacotherapy follow-up, which lasts an average 
time of 60 minutes (Oliveira, 2011), a greater number 
of patients can be seen in a shorter period of time in the 
dispensing process. Consultation time is a crucial issue 
for the quality of the public health system in Brazil, since 
there are more than 110 million users only in the primary 
care system, and an average of 0.75 pharmacist per 1000 
inhabitants (Brasil, 2013c). The work of the pharmacist 
in the dispensing process may contribute to the solution 
of numerous DRPs. Also, dispensing may be regarded as 
a screening stage to determine whether a referral to the 
pharmacy follow-up is required.
Although the study was conducted in a CP with 
structural conditions and human resources very different 
from those observed in the vast majority of the country’s 
pharmacies, it was interesting to observe how medication 
dispensing performed by the pharmacist and ideal 
conditions could significantly contribute to the rational 
use of medicines.
One limitation of the study was the limited number 
of variables assessing the association between structure, 
process and outcome of the model. Further studies 
including a greater number of variables are needed 
to elucidate the possible association between these 
components of the dispensing service. Also, further studies 
are required to assess this medication dispensing model 
in different scenarios and designs in order to evaluate the 
reproducibility of the model.
CONCLUSION
The service of medicine dispensing developed and 
implemented in the CP was able to identify and solve 
DRPs. Also, it promoted an increased level of patient 
knowledge of medications. The model of drug dispensing 
represents a component of the appropriate soft technology 
in health care, so that patients can have greater benefit from 
their pharmacotherapy.
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